Antimicrobial practice. Laboratory antibiotic susceptibility reporting and antibiotic prescribing in general practice
|
|
- Eric Ward
- 6 years ago
- Views:
Transcription
1 Journal of Antimicrobial Chemotherapy (2003) 51, DOI: /jac/dkg032 Advance Access publication 6 January 2003 Antimicrobial practice Laboratory antibiotic susceptibility reporting and antibiotic prescribing in general practice Thean Yen Tan 1 *, Cliodna McNulty 2, Andre Charlett 3, Nazma Nessa 3, Clare Kelly 4 and Trevor Beswick 4 1 Public Health Laboratory, University Hospital Wales, Cardiff, South Glamorgan CF14 4XW; 2 Public Health Laboratory, Gloucester; 3 Statistics Department, Communicable Disease Surveillance Centre, London; 4 NHS Executive South West, Department of Health, Bristol, UK Received 25 June 2002, returned 26 August 2002, revised 9 October 2002; accepted 9 October 2002 This study set out to investigate whether there was an association between antibiotic susceptibility reporting from microbiology laboratories and antibiotic prescribing for urinary tract infections in the community. Data were collected over a 3 month period using a prospective questionnaire survey of general practitioners, who submitted and received a mid-stream urine (MSU) result from selected microbiology laboratories in England and Wales. In addition, prescribing analyses and cost (PACT) data were requested from the Prescription Prescribing Authority. The study demonstrated an association between laboratory reporting of antibiotic susceptibilities and antibiotic prescribing for treatment of urinary tract infections. The reporting of susceptibilities to oral cephalosporins and nitrofurantoin from microbiology laboratories was associated with increased prescribing of each antibiotic. This association was demonstrated for the choice of empirical antibiotic therapy and the choice of antibiotic prescribed for each studied episode of urinary tract infection. PACT data demonstrated a consistently greater use of antibiotics that were reported by the servicing laboratory, although this was only statistically significant for nitrofurantoin. This study demonstrates that there is an association between antibiotic susceptibility reporting from microbiology laboratories and antibiotic prescribing for the treatment of urinary tract infections. Keywords: antibiotic reporting, prescribing, microbiology laboratory Introduction Infections constitute up to 40% of consultations in general practice. 1 General practice surgeries submit urine samples per 1000 patients and laboratory reports result in a change in antibiotic therapy in 28% of cases. 2 However, there is little information to document the influence of microbiology reports on antibiotic selection and prescribing. In the UK, microbiology laboratories invest significant efforts in the process of quality assurance 3,4 and the standardization of antimicrobial susceptibility testing methodology 5 but much less attention has been given to the choice of antibiotics to test and report. This study aimed to determine whether different antibiotic susceptibility reporting protocols for urinary isolates from microbiology laboratories was associated with differences in antibiotic prescribing in primary care. We hypothesized that general practitioners (GPs) who were served by laboratories that routinely reported particular antimicrobials (e.g. nitrofurantoin, quinolones and cephalosporins) would prescribe... *Corresponding author. Tel: ; Fax: ; theanyen.tan@phls.wales.nhs.uk The British Society for Antimicrobial Chemotherapy
2 T. Y. Tan et al. these agents more frequently for the treatment of urinary tract infections (UTIs) than doctors who were served by laboratories that did not report these antimicrobials. Materials and methods A questionnaire-based study was developed to investigate antibiotic prescribing by GPs for the treatment of UTIs that were served by laboratories with differing antibiotic reporting protocols. In addition, antibiotic prescribing for the treatment of all infections from each participating primary care group was measured by obtaining prescribing analyses and cost (PACT) data. PACT data represent the main source of information on the prescribing of GPs in England, 6 and a similar scheme exists in Wales. Questionnaire survey of antibiotic prescribing practices from general practice In total, 100 questionnaires were distributed to GPs in each primary care area serviced by 13 Public Health Laboratories over a 4 month period in the year The primary care area was delineated by obtaining a complete list of GP practices serviced by each participating laboratory. The geographical area served by these laboratories included areas throughout England and Wales. Laboratory selection was based on susceptibility reporting determined by an earlier questionnaire survey of all Public Health Laboratories in England and Wales. 7 reporting practices for each participating laboratory were confirmed by the investigators before distribution of questionnaires. All laboratories reported susceptibilities to trimethoprim and ampicillin. Two laboratories did not report susceptibilities to nitrofurantoin, five laboratories did not report susceptibilities to cephalosporins and seven did not report susceptibilities to quinolones. Questionnaires were attached to 100 consecutive positive mid-stream urine (MSU) reports at each participating laboratory. Wherever possible, laboratories were instructed to refrain from sending more than one questionnaire to an individual GP. A positive report was defined as any MSU specimen with significant growth of an isolate for which antibiotic susceptibility testing was carried out. Each questionnaire contained details of the urinary isolate identified with reported antibiotic susceptibilities, but contained no patient or practice identifiers. Completed questionnaires were initially returned to each local laboratory, and subsequently forwarded to the study investigators. GPs were asked to provide information on their antibiotic prescribing practices for uncomplicated UTIs, including the antibiotic that they had prescribed for the current investigated episode of UTI. The antibiotic choices provided for the questionnaire included amoxicillin, oral cephalosporins, quinolones, co-amoxiclav, nitrofurantoin and trimethoprim (questionnaire available from the authors). Analysis of antibiotic prescribing results from questionnaire survey prescribing of GPs was examined by two separate methods. GPs were asked to nominate their first choice of antibiotic for the treatment of uncomplicated UTIs in general. These choices were examined in order to detect any difference in empirical antibiotic choices between GPs serviced by laboratories with different antibiotic susceptibility reporting practices. GPs were then asked to name the actual antibiotic prescribed for the UTIs surveyed in each questionnaire received. The antibiotic prescribing for these episodes could be subdivided into two groups: antibiotics prescribed before receipt of the laboratory report, and antibiotics prescribed after receipt of the laboratory report. From these data, it was possible to compare the actual antibiotic prescribing for the surveyed UTIs for GPs serviced by separate laboratories. Nitrofurantoin, quinolones and cephalosporins were chosen as the indicator antimicrobials for analysis because these were the only antibiotics where differences in reporting existed between the various laboratories. It was not possible to analyse differences in antibiotic prescribing between reporting and non-reporting laboratories for ampicillin and trimethoprim, because all laboratories reported these two antibiotics. PACT data PACT data provide information about prescribing in general practice in England, and include all items prescribed by GPs and nurse prescribers. The volumes and prices of antibiotic s can be measured, but not the specific infection for which a particular antibiotic was prescribed. However, nitrofurantoin and norfloxacin are almost entirely prescribed only for the treatment of UTIs. Any regional differences in antibiotic prescribing for UTIs may therefore be measurable by PACT data for these two antibiotics. Primary care groups served solely by each participating laboratory were identified. PACT data for oral cephalosporins, co-amoxiclav, nitrofurantoin, norfloxacin, quinolones and total antibiotic prescribing were requested for every participating primary care group for the year Analysis of PACT data Statistical analysis of the PACT data was carried out on Microsoft Excel and Stata 7. Due to an observed positive skew in the antibiotic prescribing units, the data were logtransformed before the analysis. A t-test was then carried out to assess whether there was a significant difference in prescribing in the areas where an antibiotic is reported compared with where the antibiotic is not reported. As well as the reported s, the estimated ratio of prescribing in the 380
3 susceptibility reporting and prescribing in general practice Table 1. Comparison of stated empirical antibiotic of first choice by GPs Number of GPs (%) who selected this antibiotic as first-choice empirical therapy for uncomplicated UTIs Oral cephalosporins 52/592 (8) 6/313 (2) < ( ) Nitrofurantoin 13/869 (2) 0/169 (0) 0.1 undefined Quinolones 1/410 (0) 6/474 (1) ( ) Figures in parentheses are reported as a percentage of the denominator. Table 2. Actual antibiotic prescribing by GPs for the episode of UTI investigated Number of GPs who prescribed this antibiotic for the investigated episodes of UTI (%) Oral cephalosporins 100/616 (16) 31/300 (10) ( ) Nitrofurantoin 35/835 (4) 0/149 (0) 0.01 undefined Quinolones 45/459 (10) 24/383 (6) ( ) Figures in parentheses are reported as a percentage of the denominator. reporting to non-reporting areas was calculated together with the 95% confidence intervals. Statistical analysis Data from the questionnaires and PACT data were entered into Epi-Info, and analysed in Stata 7 and Epi-Info. The χ 2 test and Fisher s exact test were used to test for statistical significance for any associations noted. Results In total, 1069 of 1300 (82%, range 65 90%) distributed questionnaires were returned. GPs stated empirical antibiotic choices Overall, 90% of GPs selected trimethoprim as antibiotic of first choice in uncomplicated UTIs. The other empirical antibiotic choices selected were an oral cephalosporin (6%) and a quinolone (1%). However, GPs in areas serviced by a laboratory that routinely reported cephalosporin susceptibilities on urinary isolates were four times more likely to select an oral cephalosporin as their first choice of empirical therapy (Table 1). No statistically significant differences in the choice of either quinolones or nitrofurantoin were noted for GPs serviced by laboratories that reported or did not report each antibiotic. GPs prescribed antibiotic therapy for the investigated episode of UTI With regard to antibiotic prescribing for the reported cases of UTI in this study, GPs who were serviced by laboratories that reported cephalosporins or nitrofurantoin were significantly more likely to prescribe these antibiotics (Table 2). In laboratory areas where cephalosporin susceptibilities were reported, 16% of GPs prescribed this antibiotic as opposed to 10% in non-reporting areas (P < 0.05). The corresponding figures for quinolone prescribing were 10% in reporting areas, compared with 6% in non-reporting areas (P = 0.06); 4% of GPs serviced by laboratories that reported antibiotic susceptibilities to nitrofurantoin prescribed this antibiotic, compared with 0% in the corresponding group serviced by a non-reporting laboratory (P < 0.05). Subgroup analysis was carried out to compare antibiotic both before and after receipt of the laboratory result. 381
4 T. Y. Tan et al. Table 3. therapy prescribed by GPs before receipt of laboratory MSU report prescribed for investigated episode of UTI before receipt of microbiology report (%) Nitrofurantoin 16/501 (3) 0/87 (0) 0.07 undefined Oral cephalosporins 50/364 (14) 16/181 (9) ( ) Quinolones 32/277 (12) 11/226 (5) < ( ) Table 4. therapy prescribed by GPs after receipt of laboratory MSU report prescribed for investigated episode of UTI after receipt of microbiology report (%) Nitrofurantoin 19/334 (6) 0/62 (0) 0.04 undefined Oral cephalosporins 50/252 (20) 15/119 (13) ( ) Quinolones 13/182 (7) 13/157 (8) ( ) Table 5. Comparison of antibiotic prescribing as measured by PACT data from reporting and non-reporting laboratory areas Estimated ratio of antibiotic prescribing (laboratories that report antibiotic/laboratories that do not report antibiotic) 95% CI Cephalosporins Quinolones Norfloxacin 1.29 (laboratories that report quinolones/laboratories that do not report quinolones) Norfloxacin 2.08 (laboratories that report norfloxacin/laboratories that do not report norfloxacin) Nitrofurantoin Co-amoxiclav Combined analysis Before receipt of the laboratory result, GPs served by any laboratory that reported quinolone susceptibilities were more than twice as likely to have initially prescribed this antibiotic (12% versus 5%, P < 0.01) (Table 3). The strongest association between antibiotic reporting and prescribing following receipt of the laboratory report was for nitrofurantoin (6% versus 0%, P = 0.04) (Table 4). Although more GPs who were served by laboratories that reported cephalosporin susceptibilities prescribed cephalosporins following receipt of the microbiology report, this increase was not statistically significant. PACT data Analysis of the PACT data was carried out to investigate whether these reported differences in antibiotic selection and prescribing were quantifiable as differences in antibiotic and cost data (Table 5). Prescribing volumes for nitrofurantoin were nearly three times higher in primary care areas served by a reporting laboratory (P < 0.05). For all the other antibiotics concerned, prescribing of an antibiotic was higher in areas served by the laboratories that reported the antibiotic, although the results failed to reach statistical sig- 382
5 susceptibility reporting and prescribing in general practice nificance. Initially an interaction was used to test for heterogeneity between the estimated ratio of antibiotic prescribing, and there was no evidence to suggest that the relative increases in prescribing in the areas served by reporting laboratories were different (P = 0.33). The final row in Table 5 was obtained by pooling these estimates in a regression model. These figures demonstrate that, regardless of which individual antibiotic is examined, laboratory reporting of any antibiotic is associated with a 54% increase in antibiotic prescribing (P = 0.024, 95% CI 6 123%). Discussion There is conflicting evidence from previous literature regarding the link between laboratory antimicrobial susceptibility reporting and antibiotic prescribing. An earlier study that restricted susceptibility reporting on urinary isolates from the community showed increasing use of the antibiotics for which susceptibilities were reported. 8 This study demonstrates that the prescribing of cephalosporins, nitrofurantoin and quinolones for the treatment of UTIs varies across general practices. These reported differences extended from the choice of empirical antibiotics to the actual of antibiotics for the UTIs surveyed in this study, and corresponded with local laboratory antibiotic susceptibility reporting. Laboratory reporting of quinolone or cephalosporin susceptibilities by a microbiology laboratory was associated with a 50% increase in prescribing of each antibiotic by the GPs surveyed in this study, whereas the difference for nitrofurantoin prescribing was substantially larger. Other than for nitrofurantoin, these reported differences in prescribing did not translate into a significant difference in actual antibiotic prescribing as reported by PACT data. There was a trend towards increased antibiotic prescribing linked with antibiotic reporting. However, with such small numbers of laboratories involved, the analysis did not have sufficient statistical power to detect the reported differences as being significant. In addition, PACT data are not specific enough to differentiate between antibiotics prescribed for the treatment of UTIs or other infections. Thus, it is difficult to demonstrate an association between reporting and prescribing of some antibiotics specifically for the treatment of UTIs. Cephalosporins, co-amoxiclav and quinolones can also be prescribed for treatment of other infections. There are several limitations to this study. The sample of GPs in the study was clearly biased towards those who submitted urine samples to their local laboratory. The prescribing practices of doctors who rarely submit urine samples for testing may be different from those surveyed in this study. Some GPs may only submit MSU samples for the treatment of complicated UTIs, which may require different empirical antibiotic treatment. It may not be possible to extrapolate these results to all primary care areas in England and Wales. Only 100 GPs were sampled for each primary care area involved in the study. Furthermore, only primary care areas served by Public Health Laboratories were included in the study. Laboratories were selected for participation in the study by their local antibiotic reporting practices and not by geographical distribution or demographic coverage. Because of these factors, the sample population may not be representative of the general population as a whole. Variation in local antibiotic susceptibility patterns may also account for the differences in antibiotic prescribing. For example, higher rates of resistance to ampicillin, nitrofurantoin or trimethoprim may account for increased of cephalosporins or quinolones. susceptibilities of the reported 100 urinary isolates from each laboratory were analysed for antibiotic resistance rates to ampicillin, nitrofurantoin or trimethoprim (data available on request). The only significant difference in resistance rates noted was increased resistance to ampicillin/amoxicillin in laboratories that reported norfloxacin susceptibilities (resistance rate 59% versus 46%, P < 0.05). Even in this laboratory grouping, there was no significant difference in resistance rates to trimethoprim or nitrofurantoin. This study has demonstrated an association between laboratory susceptibility reporting practices and the prescribing of specific antibiotics for the treatment of UTIs. This association was noted at both possible stages of antibiotic prescribing in the choice of empirical antibiotic therapy, and in prescribing for an infection when the susceptibility results were known. It is less clear whether this association would be applicable to all antibiotics prescribed for UTIs, or to antibiotics prescribed for other infections. In a study of this nature, causality is difficult to demonstrate. For example, one possible explanation for the association noted in this study is that microbiology laboratories may selectively choose to report antibiotics that are more commonly used in their primary care area. It would be difficult to ascertain the relative effect of the actual microbiology report itself, and other influences such as local antibiotic reporting practices in general and local prescribing guidelines. In addition, the laboratory report may affect antibiotic prescribing at various stages in the process in the overall decision making process, or at the actual stage of selection and prescribing of the antibiotic. It is well documented that influences on prescribing habits are complex and multi-factorial and include prescribing guidelines, 9 education, 10 the pharmaceutical industry 11 and patient expectations. 12 Nonetheless, the results from this study suggest that laboratory reporting of antibiotic susceptibilities may influence antibiotic prescribing in the community. Further studies will be needed to clarify this association, for example, by altering laboratory reporting practices in the study areas and 383
6 T. Y. Tan et al. examining the effect of this alteration on subsequent antibiotic prescribing. Acknowledgements We would like to thank the Directors and staff of the following Public Health Laboratories without whom this study would not have been possible: Bangor, Bristol, Cardiff, Chester, Chelmsford, Coventry, Exeter, Gloucester, Ipswich, Lincoln, Norwich, Plymouth and Shrewsbury. We also thank all the GPs who contributed to the questionnaire survey. This study was funded by a grant from the Public Health Laboratory Service. References 1. UK Department of Health. (2002). Getting ahead of the curve. A strategy for combating infectious diseases (including other aspects of health protection) [Online.] (24 July 2002, date last accessed). 2. Tompkins, D. S. & Shannon, A. M. (1993). Clinical value of microbiological investigations in general practice. British Journal of General Practice 43, Gray, J. (1999). Quality assurance in a diagnostic microbiology laboratory. Communicable Disease and Public Health 2, Bartlett, R. C., Mazens-Sullivan, M., Tetreault, J. Z., Lobel, S. & Nivard, J. (1994). Evolving approaches to management of quality in clinical microbiology. Clinical Microbiology Review 7, Andrews, J. M. (2001). BSAC Working Party on Susceptibility Testing. BSAC standardized disc susceptibility testing method. Journal of Antimicrobial Chemotherapy 48, Suppl. 1, Majeed, A., Evans, N. & Head, P. (1997). What can PACT tell us about prescribing in general practice? British Medical Journal 315, Tan, T. Y. & McNulty, C. A. (2002). Survey of public health laboratory protocols for reporting the antibiotic susceptibility of urinary isolates submitted from general practice. Communicable Disease and Public Health 5, Langdale, P. & Millar, M. R. (1986). Influence of laboratory sensitivity reporting on antibiotic prescribing preferences of general practitioners in the Leeds area. Journal of Clinical Pathology 39, Zwar, N., Wolk, J., Gordon, J., Sanson-Fisher, R. & Kehoe, L. (1999). Influencing antibiotic prescribing in general practice: a trial of prescriber feedback and management guidelines. Family Practice 16, McNulty, C. A., Kane, A., Foy, C. J., Sykes, J., Saunders, P. & Cartwright, K. A. (2000). Primary care workshops can reduce and rationalize antibiotic prescribing. Journal of Antimicrobial Chemotherapy 46, Orlowski, J. P. & Wateska, L. (1992). The effects of pharmaceutical firm enticements on physician prescribing patterns. There s no such thing as a free lunch. Chest 102, Macfarlane, J., Holmes, W., Macfarlane, R. & Britten, N. (1997). Influence of patients expectations on antibiotic management of acute lower respiratory tract illness in general practice: questionnaire study. British Medical Journal 315,
Protocol for Surveillance of Antimicrobial Resistance in Urinary Isolates in Scotland
Protocol for Surveillance of Antimicrobial Resistance in Urinary Isolates in Scotland Version 1.0 23 December 2011 General enquiries and contact details This is the first version (1.0) of the Protocol
More informationCephalosporins, Quinolones and Co-amoxiclav Prescribing Audit
Cephalosporins, Quinolones and Co-amoxiclav Prescribing Audit Executive Summary Background Antibiotic resistance poses a significant threat to public health, as antibiotics underpin routine medical practice.
More informationake National Point Prevalence Survey of Healthcare Associated Infections, Device usage and Antimicrobial use in Long-Term Care Facilities 2017 HALT-3
ake National Point Prevalence Survey of Healthcare Associated Infections, Device usage and Antimicrobial use in Long-Term Care Facilities 2017 HALT-3 Wales HCAI and AMR Programme The Healthcare Associated
More informationTandan, Meera; Duane, Sinead; Vellinga, Akke.
Provided by the author(s) and NUI Galway in accordance with publisher policies. Please cite the published version when available. Title Do general practitioners prescribe more antimicrobials when the weekend
More informationRESEARCH. Ashley Bryce, 1 Alastair D Hay, 1 Isabel F Lane, 1 Hannah V Thornton, 1 Mandy Wootton, 2 Céire Costelloe 3. open access
open access Global prevalence of antibiotic resistance in paediatric urinary tract infections caused by Escherichia coli and association with routine use of antibiotics in primary care: systematic review
More informationBy Leah Jones, Research Assistant, Primary Care Unit Public Health England
A modified McNulty-Zelen design randomised controlled trial to evaluate the TARGET Antibiotics toolkit (Treat Antibiotics Responsibly, Guidance, Education, Tools) and its implementation By Leah Jones,
More informationQuality indicators and outcomes in the devolved nations Scotland
Quality indicators and outcomes in the devolved nations Scotland Dr Jacqueline Sneddon, MRPharmS Project Lead, Scottish Antimicrobial Prescribing Group Federation of Infection Societies Conference Birmingham,
More informationPrescribing Quality Scheme 2017/18
Prescribing Quality Scheme 2017/18 In line with national policy and the Quality Premium, we are continuing to promote good antimicrobial stewardship and, therefore, include this element in an incentive
More informationWELSH HEALTH CIRCULAR
WELSH HEALTH CIRCULAR WHC/2018/020 Issue Date: 4 May 2018 STATUS: ACTION & INFORMATION CATEGORY: QUALITY AND SAFETY Title: AMR IMPROVEMENT GOALS & HCAI REDUCTION EXPECTATIONS BY MARCH 2019: PRIMARY & SECONDARY
More informationDr Eleri Davies. Consultant Microbiologist and Infection Control Doctor, Public Health Wales NHS Trust
Dr Eleri Davies Consultant Microbiologist and Infection Control Doctor, Public Health Wales NHS Trust Antimicrobial stewardship What is it? Why is it important? Treatment and management of catheter-associated
More informationCork and Kerry SARI Newsletter; Vol. 2 (2), December 2006
Cork and SARI Newsletter; Vol. 2 (2), December 6 Item Type Newsletter Authors Murray, Deirdre;O'Connor, Nuala;Condon, Rosalind Download date 31/1/18 15:27:31 Link to Item http://hdl.handle.net/1147/67296
More informationFIS Resistance Surveillance: The UK Landscape. Alasdair MacGowan Chair BSAC Working Party on Antimicrobial Resistance Surveillance
FIS 2013 Resistance Surveillance: The UK Landscape Alasdair MacGowan Chair BSAC Working Party on Antimicrobial Resistance Surveillance A statement of the obvious Good quality surveillance data on resistant
More informationVolume 1; Number 7 November 2007
Volume 1; Number 7 November 2007 CONTENTS Page 1 Page 3 Guidance on the Use of Antibacterial Drugs in Lincolnshire Primary Care: Winter 2007/8 NICE Clinical Guideline 54: Urinary Tract Infection in Children
More informationUrinary Tract Infection Workshop
Urinary Tract Infection Workshop Diagnosis, sampling, antibiotic selection, recurrence, prophylaxis Nick Francis, Robin Howe, Harry Ahmed Outline Diagnosis and sampling Nick 10 min Choice of antibiotic
More informationHalting Infections in Long Term Care
Results of HALT Study 2013 Halting Infections in Long Term Care HALT Seminar Novemeber 2014 DR Nuala O Connor ICGP Lead HCAI AMR DR Bartley Cryan Consultant microbiologist CUH Dr Paul Gallagher Consultant
More informationPrior antibiotics and risk of antibiotic-resistant community-acquired urinary tract infection: a case control study
Journal of Antimicrobial Chemotherapy (2007) 60, 92 99 doi:10.1093/jac/dkm141 Advance Access publication 30 May 2007 Prior antibiotics and risk of antibiotic-resistant community-acquired urinary tract
More informationMarc Decramer 3. Respiratory Division, University Hospitals Leuven, Leuven, Belgium
AAC Accepts, published online ahead of print on April 0 Antimicrob. Agents Chemother. doi:./aac.0001- Copyright 0, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.
More informationAntibacterial Resistance In Wales
A Report from Public Health Wales Antimicrobial Resistance Programme Surveillance Unit: Antibacterial Resistance In Wales 2005-2012 Authors: Maggie Heginbothom Robin Howe & Catherine Thomas Version: 1
More informationQuality and Safety Committee
SUMMARY REPORT Quality and Safety Committee ABM University Health Board Meeting On 20 TH OCTOBER 2016 Subject Prepared by Approved & Presented by Purpose Big Fight Campaign AGENDA ITEM: 2.2 Debra Woolley
More informationTREAT Steward. Antimicrobial Stewardship software with personalized decision support
TREAT Steward TM Antimicrobial Stewardship software with personalized decision support ANTIMICROBIAL STEWARDSHIP - Interdisciplinary actions to improve patient care Quality Assurance The aim of antimicrobial
More informationAntibiotic Review Kit - Hospital
The International Convention Centre (ICC), Birmingham 11 12 September 2017 Antibiotic Review Kit - Hospital (ARK-hospital) Elizabeth Cross Brighton and Sussex University Hospitals NHS Trust Brighton and
More informationAntibacterial Resistance in Wales
Antibacterial Resistance in Wales 2006-2015 June 2016 Microbiology Division, Public Health Wales Table of Contents Table of Contents... 1 Section 1: Introduction... 2 Section 2: Key points of interest...
More informationAntibacterial Resistance In Wales
A Report from Public Health Wales Antimicrobial Resistance Programme Surveillance Unit: Antibacterial Resistance In Wales 2005-2013 Authors: Maggie Heginbothom and Robin Howe Version: 1 Antibacterial Resistance
More informationAntimicrobial practice. Primary care workshops can reduce and rationalize antibiotic prescribing
Journal of Antimicrobial Chemotherapy (2000) 46, 493 499 JAC Antimicrobial practice Primary care workshops can reduce and rationalize antibiotic prescribing Cliodna A. M. McNulty a *, Alan Kane b, Chris
More information* Author to whom correspondence should be addressed; Tel.:
Antibiotics 2014, 3, 29-38; doi:10.3390/antibiotics3010029 Article OPEN ACCESS antibiotics ISSN 2079-6382 www.mdpi.com/journal/antibiotics Antibiotic Prescribing in Primary Care and Antimicrobial Resistance
More informationPredictors of the Diagnosis and Antibiotic Prescribing to Patients Presenting with Acute Respiratory Infections
Predictors of the Diagnosis and Antibiotic Prescribing to Patients Presenting with Acute Respiratory Infections BY RYAN JOERRES CAPSTONE COMMITTEE MEMBERS: DENNIS J. BAUMGARDNER, MD, AJAY K. SETHI, PH.D.,
More informationAntimicrobial Update Stewardship in Primary Care. Clare Colligan Antimicrobial Pharmacist NHS Forth Valley
Antimicrobial Update Stewardship in Primary Care Clare Colligan Antimicrobial Pharmacist NHS Forth Valley Setting the Scene! Consequences of Antibiotic Use? Resistance For an individual patient with
More informationWhat can we learn from point prevalence surveys? Mark Gilchrist Consultant Pharmacist Infectious Diseases
What can we learn from point prevalence surveys? Mark Gilchrist Consultant Pharmacist Infectious Diseases Imperial College Healthcare NHS Trust mark.gilchrist@imperial.nhs.uk Outline Placing point prevalence
More informationTable 2.01 Overview of Surveillance programs in the Netherlands. available since. GP, laboratories Decentral Hospital,
2 Extensive summary In the Netherlands, several surveillance programs have been developed to monitor antimicrobial resistance in important pathogens in different settings (SERIN, SIRIN, ISIS- AR). In addition,
More informationTitle: Antibacterial resistances in uncomplicated urinary tract infections in women: ECO * SENS II data from primary health care in Austria
Author's response to reviews Title: Antibacterial resistances in uncomplicated urinary tract infections in women: ECO * SENS II data from primary health care in Austria Authors: Gustav Kamenski (kamenski@aon.at)
More informationVolume. December Infection. Notes. length of. cases as 90% 1 week. tonsillitis. First Line. sore throat / daily for 5 days. quinsy >4000.
Volume 8; Number 22 LINCOLNSHIRE GUIDELINES FOR THE TREATMENT OF COMMONLYY OCCURRING INFECTIONS IN PRIMARY CARE: WINTER 2014/15 In this issue of the PACE Bulletin we present an update of our Guidelines
More informationPrimary care. Antibacterial prescribing and antibacterial resistance in English general practice: cross sectional study. Abstract.
Antibacterial prescribing and antibacterial resistance in English general practice: cross sectional study Patricia Priest, Patricia Yudkin, Cliodna McNulty, David Mant Abstract Objective To quantify the
More informationVaccine Evaluation Center, BC Children s Hospital Research Institute, 950 West 28 th Ave,
Manuscript Click here to view linked References Age-specific trends in antibiotic resistance in Escherichia coli infections in Oxford, United Kingdom 2013-2014 Rebecca C Robey a, Simon B Drysdale b,c,
More informationBuilding Rapid Interventions to reduce antimicrobial resistance and overprescribing of antibiotics (BRIT)
Greater Manchester Connected Health City (GM CHC) Building Rapid Interventions to reduce antimicrobial resistance and overprescribing of antibiotics (BRIT) BRIT Dashboard Manual Users: General Practitioners
More informationHealthcare Facilities and Healthcare Professionals. Public
Document Title: DOH Guidelines for Antimicrobial Stewardship Programs Document Ref. Number: DOH/ASP/GL/1.0 Version: 1.0 Approval Date: 13/12/2017 Effective Date: 14/12/2017 Document Owner: Applies to:
More informationModels for stewardship in Hospital - UK Models Philip Howard Consultant Antimicrobial Pharmacist
Models for stewardship in Hospital - UK Models Philip Howard Consultant Antimicrobial Pharmacist philip.howard2@nhs.net Twitter: @AntibioticLeeds United Kingdom of England, Scotland, Wales & Northern Ireland
More informationInvestigation of antibiotic prescribing and antibiotic resistance in humans.
Investigation of antibiotic prescribing and antibiotic resistance in humans. Katie Stewart Supervised by: Louise Matthews, Marian Scott, Dirk Husmeier and Colin McCowan k.stewart.3@research.gla.ac.uk 18th
More informationImpact of NHS England Quality Indicators on Antimicrobial Resistance. Professor Alan Johnson National Infection Service Public Health England
Impact of NHS England Quality Indicators on Antimicrobial Resistance Professor Alan Johnson National Infection Service Public Health England A Risk Assessment of Antibiotic Pan-Drug Resistance in the UK:
More informationConcise Antibiogram Toolkit Background
Background This toolkit is designed to guide nursing homes in creating their own antibiograms, an important tool for guiding empiric antimicrobial therapy. Information about antibiograms and instructions
More informationWhat s happening across the UK with antimicrobial prescribing quality indicators?
What s happening across the UK with antimicrobial prescribing quality indicators? Dr Jacqueline Sneddon, MRPharmS Project Lead, Scottish Antimicrobial Prescribing Group Antimicrobial Management Team Network
More informationThe UK 5-year AMR Strategy - a brief overview - Dr Berit Muller-Pebody National Infection Service Public Health England
The UK 5-year AMR Strategy - a brief overview - Dr Berit Muller-Pebody National Infection Service Public Health England Chief Medical Officer - Annual Report 2013 Antimicrobial resistance poses catastrophic
More informationCommonwealth of Kentucky Antibiotic Stewardship Practice Assessment For Long-Term Care Facilities
Commonwealth of Kentucky Antibiotic Stewardship Practice Assessment For Long-Term Care Facilities Introduction As the problem of antibiotic resistance continues to worsen in all healthcare setting, we
More informationAntimicrobial use in humans
Antimicrobial use in humans Ann Versporten Prof. Herman Goossens OIE Global Conference on the Responsible and Prudent Use of Antimicrobial Agents for Animals - 13 March 2013 - Ann.versporten@ua.ac.be Herman.goossens@uza.be
More informationAntimicrobial Resistance and Dentistry. LDC Officials Day 4 December 2015 Susie Sanderson
Antimicrobial Resistance and Dentistry LDC Officials Day 4 December 2015 Susie Sanderson Who am I? Why are we interested in AMR? Where is the leadership? Who is taking action? What is the BDA doing? Is
More informationA retrospective analysis of urine culture results issued by the microbiology department, Teaching Hospital, Karapitiya
A retrospective analysis of urine culture results issued by the microbiology department, Teaching Hospital, Karapitiya LU Edirisinghe 1, D Vidanagama 2 1 Senior Registrar in Medicine, 2 Consultant Microbiologist,
More information1. The preferred treatment option for an initial UTI episode in a 22-year-old female patient
1 Chapter 79, Self-Assessment Questions 1. The preferred treatment option for an initial UTI episode in a 22-year-old female patient with normal renal function is: A. Trimethoprim-sulfamethoxazole B. Cefuroxime
More informationAntimicrobial Stewardship-way forward. Dr. Sonal Saxena Professor Lady Hardinge Medical College New Delhi
Antimicrobial Stewardship-way forward Dr. Sonal Saxena Professor Lady Hardinge Medical College New Delhi Lets save what we have! What is Antibiotic stewardship? Optimal selection, dose and duration of
More informationUnderstanding the Hospital Antibiogram
Understanding the Hospital Antibiogram Sharon Erdman, PharmD Clinical Professor Purdue University College of Pharmacy Infectious Diseases Clinical Pharmacist Eskenazi Health 5 Understanding the Hospital
More informationEnglish Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR)
English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR) Berit Muller-Pebody HCAI & AMR Department, Centre for Infectious Disease Surveillance and Control Chief Medical Officer
More informationNational Point Prevalence Survey of Healthcare Associated Infection, Device Usage and Antimicrobial Prescribing Wales. HCAI and AMR Programme
National Point Prevalence Survey of Healthcare Associated Infection, Device Usage and Antimicrobial Prescribing 2017 Wales HCAI and AMR Programme The Healthcare Associated Infection and Antimicrobial Resistance
More informationAntibiotic Susceptibility Patterns of Community-Acquired Urinary Tract Infection Isolates from Female Patients on the US (Texas)- Mexico Border
Antibiotic Susceptibility Patterns of Community-Acquired Urinary Tract Infection Isolates from Female Patients on the US (Texas)- Mexico Border Yvonne Vasquez, MPH W. Lee Hand, MD Department of Research
More informationAntimicrobial Stewardship in Ambulatory Care
Antimicrobial Stewardship in Ambulatory Care Nila Suntharam, M.D. May 5, 2017 Dr. Suntharam indicated no potential conflict of interest to this presentation. She does not intend to discuss any unapproved/investigative
More informationAntimicrobial Stewardship Programs The Same, but Different. Sara Nausheen, MD Kevin Kern, PharmD
Antimicrobial Stewardship Programs The Same, but Different Sara Nausheen, MD Kevin Kern, PharmD Antimicrobial Stewardship Programs The Same, but Different Objectives: Outline the overall function of an
More informationPOINT PREVALENCE SURVEY A tool for antibiotic stewardship in hospitals. Koen Magerman Working group Hospital Medicine
POINT PREVALENCE SURVEY A tool for antibiotic stewardship in hospitals Koen Magerman Working group Hospital Medicine Background Strategic plan By means of a point prevalence survey and internal audits
More informationABSTRACT ORIGINAL RESEARCH. Gunnar Kahlmeter. Jenny Åhman. Erika Matuschek
Infect Dis Ther (2015) 4:417 423 DOI 10.1007/s40121-015-0095-5 ORIGINAL RESEARCH Antimicrobial Resistance of Escherichia coli Causing Uncomplicated Urinary Tract Infections: A European Update for 2014
More informationCommunity-Acquired Pneumonia: Severity scoring and compliance to BTS guidelines. Julie Harris Antibiotic Pharmacist Hywel Dda Healthboard
Community-Acquired Pneumonia: Severity scoring and compliance to BTS guidelines Julie Harris Antibiotic Pharmacist Hywel Dda Healthboard Plan Background BTS guidelines Differences in opinion Measures introduced
More informationVolume 2; Number 16 October 2008
Volume 2; Number 16 October 2008 What s new this month NHS Lincolnshire have launched a public information campaign designed to raise public awareness of the risks associated with the inappropriate use
More informationIntroduction. Antimicrobial Usage ESPAUR 2014 Previous data validation Quality Premiums Draft tool CDDFT Experience.
Secondary Care Data Validation: What do commissioners need to know? Stuart Brown Healthcare Acquired Infection and Antimicrobial Resistance Project Lead NHS England March 2014 Introduction Antimicrobial
More informationPromoting Appropriate Antimicrobial Prescribing in Secondary Care
Promoting Appropriate Antimicrobial Prescribing in Secondary Care Stuart Brown Healthcare Acquired Infection and Antimicrobial Resistance Project Lead NHS England March 2015 Introduction Background ESPAUR
More informationBacterial infections in the urinary tract
Zurich Open Repository and Archive University of Zurich Main Library Strickhofstrasse 39 CH-8057 Zurich www.zora.uzh.ch Year: 2014 Bacterial infections in the urinary tract Gerber, B Posted at the Zurich
More informationAntimicrobial Use Toolkit Webinar M A R C H 1 3,
Antimicrobial Use Toolkit Webinar M A R C H 1 3, 2 0 1 8 Welcome & Housekeeping Thank you for attending! HMS data abstractors Administrators QI staff Pharmacists Hospitalists ID physicians Individuals
More informationGENERAL NOTES: 2016 site of infection type of organism location of the patient
GENERAL NOTES: This is a summary of the antibiotic sensitivity profile of clinical isolates recovered at AIIMS Bhopal Hospital during the year 2016. However, for organisms in which < 30 isolates were recovered
More informationAntibacterial Resistance In Wales
A Report from Public Health Wales Healthcare Associated Infection, Antimicrobial Resistance & Prescribing Programme (HARP team) Antibacterial Resistance In Wales 2008-2017 Authors: Maggie Heginbothom,
More informationReceived: Accepted: Access this article online Website: Quick Response Code:
Indian Journal of Drugs, 2016, 4(3), 69-74 ISSN: 2348-1684 STUDY ON UTILIZATION PATTERN OF ANTIBIOTICS AT A PRIVATE CORPORATE HOSPITAL B. Chitra Department of Pharmacy Practice, College of Pharmacy, Sri
More informationStewardship: Challenges & Opportunities in the Gulf Region
Stewardship: Challenges & Opportunities in the Gulf Region Mushira Enani, MBBS, FRCPE, FACP,CIC Head- Infectious Disease Section King Fahad Medical City Outline Background of Healthcare system in GCC GCC
More informationBest Practice Guidelines for Treatment of Uncomplicated UTIs in Women While Decreasing Risk of Antibiotic Resistance
The Henderson Repository is a free resource of the Honor Society of Nursing, Sigma Theta Tau International. It is dedicated to the dissemination of nursing research, researchrelated, and evidence-based
More informationThe trinity of infection management: United Kingdom coalition statement
* The trinity of infection management: United Kingdom coalition statement This coalition statement, on behalf of our organizations (the UK Sepsis Trust, Royal College of Nursing, Infection Prevention Society,
More informationAntimicrobial Stewardship
Antimicrobial Stewardship Report: 11 th August 2016 Issue: As part of ensuring compliance with the National Safety and Quality Health Service Standards (NSQHS), Yea & District Memorial Hospital is required
More informationSurveillance of AMR in PHE: a multidisciplinary,
Surveillance of AMR in PHE: a multidisciplinary, integrated approach Professor Neil Woodford Antimicrobial Resistance & Healthcare Associated Infections (AMRHAI) Reference Unit Crown copyright International
More informationGuidelines on prescribing antibiotics. For physicians and others in Denmark
Guidelines on prescribing antibiotics 2013 For physicians and others in Denmark Guidelines on prescribing antibiotics For physicians and others in Denmark 2013 by the Danish Health and Medicines Authority.
More informationOptimizing Antimicrobial Stewardship Activities Based on Institutional Resources
Optimizing Antimicrobial Stewardship Activities Based on Institutional Resources Andrew Hunter, PharmD, BCPS Infectious Diseases Clinical Pharmacy Specialist Michael E. DeBakey VA Medical Center Andrew.hunter@va.gov
More informationREPORT ON POINT PREVALENCE SURVEY OF ANTIMICROBIAL PRESCRIPTION IN EUROPEAN NURSING HOMES, November 2009
REPORT ON POINT PREVALENCE SURVEY OF ANTIMICROBIAL PRESCRIPTION IN EUROPEAN NURSING HOMES, November 29 ESAC-3: Nursing Home Subproject Group Broex E, Jans B, Latour K, Goossens H and the ESAC management
More informationrates adjusted for age, sex, infection subclass, and type of antibiotic treatment used) by British Medical Journal Publishing Group
Antibiotic treatment failure in four common infections in UK primary care 1991-2012: longitudinal analysis Craig J Currie BMJ 2014;349:g5493 23 September 2014 More than one in 10 initial antibiotic monotherapies
More informationUpdate on Fluoroquinolones. Charles Krasner, M.D. June 16, 2016 Antibiotic Stewardship Program -ECHO
Update on Fluoroquinolones Charles Krasner, M.D. June 16, 2016 Antibiotic Stewardship Program -ECHO Potential fluoroquinolone side-effects Increased risk, greater than with most other antibiotics, for
More information11/22/2016. Antimicrobial Stewardship Update Disclosures. Outline. No conflicts of interest to disclose
Antimicrobial Stewardship Update 2016 APIC-CI Conference November 17 th, 2016 Jay R. McDonald, MD Chief, ID Section VA St. Louis Health Care System Assistant Professor of medicine Washington University
More informationAcute Pyelonephritis POAC Guideline
Acute Pyelonephritis POAC Guideline Refer full regional pathway http://aucklandregion.healthpathways.org.nz/33444 EXCLUSION CRITERIA: COMPLICATED PYELONEPHRITIS Discuss with relevant specialist for advice
More informationBurden of disease of antibiotic resistance The example of MRSA. Eva Melander Clinical Microbiology, Lund University Hospital
Burden of disease of antibiotic resistance The example of MRSA Eva Melander Clinical Microbiology, Lund University Hospital Discovery of antibiotics Enormous medical gains Significantly reduced morbidity
More informationAntibacterial Usage in Primary Care In Wales 2013/ /18
A Report from Public Health Wales Healthcare Associated Infection, Antimicrobial Resistance & Prescribing Programme (HARP team) Antibacterial Usage in Primary Care In Wales 2013/14-2017/18 Authors: Maggie
More informationInappropriate Use of Antibiotics and Clostridium difficile Infection. Jocelyn Srigley, MD, FRCPC November 1, 2012
Inappropriate Use of Antibiotics and Clostridium difficile Infection Jocelyn Srigley, MD, FRCPC November 1, 2012 Financial Disclosures } No conflicts of interest } The study was supported by a Hamilton
More informationGUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS
Version 3.1 GUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS Date ratified June 2008 Updated March 2009 Review date June 2010 Ratified by Authors Consultation Evidence base Changes
More informationCLINICAL AUDIT. Prescribing amoxicillin clavulanate appropriately
CLINICAL AUDIT Prescribing amoxicillin clavulanate appropriately Valid to September 2018 bpac nz better medicin e Background Amoxicillin clavulanate is a broad spectrum antibiotic used in primary care
More informationURINARY TRACT infections
National Patterns in the Treatment of Urinary Tract Infections in Women by Ambulatory Care Physicians Elbert S. Huang, MD, MPH; Randall S. Stafford, MD, PhD ORIGINAL INVESTIGATION Background: Trimethoprim-sulfamethoxazole
More informationWorkplan on Antibiotic Usage Management
IMPACT Forum: Antibiotic Guideline in Perspective Workplan on Antibiotic Usage Management Dr. Raymond Yung Consultant Microbiologist PYNEH 20 April 2002 May 2002 Dr. Raymond Yung 1 Objective 1. Heighten
More informationThese recommendations were approved for use by the Pharmaceutical and Therapeutics Committee, RCWMCH on 1 February 2017.
Antibiotic regimens for suspected hospital-acquired infection (HAI) outside the Paediatric Intensive Care Unit at Red Cross War Memorial Children s Hospital (RCWMCH) Lead author: Brian Eley Contributing
More informationAdvances in Antimicrobial Stewardship (AMS) at University Hospital Southampton
Advances in Antimicrobial Stewardship (AMS) at University Hospital Southampton Dr Julian Sutton Consultant in Infectious Diseases & Medical Microbiology Federation of Infection Societies 1 st December,
More informationGhinwa Dumyati, MD Christina Felsen, MPH University of Rochester Medical Center
Ghinwa Dumyati, MD Christina Felsen, MPH University of Rochester Medical Center How do you decide where to start? Start small; core elements recommend you focus on one thing at a time Use data to help
More informationSwedish strategies and methods to combat antibiotic resistance
Swedish strategies and methods to combat antibiotic resistance Stephan Stenmark MD, PhD, County Medical Officer Västerbotten County Council, Sweden Head of Department for communicable disease control and
More informationUsing Data to Track Antibiotic Use and Outcomes
Using Data to Track Antibiotic Use and Outcomes Michelle Nemec, PharmD Thrifty White Drug Pharmacy Objectives Describe the Antibiotic Stewardship Core Element of tracking and the specific interventions
More informationTECHNOLOGY OVERVIEW: PHARMACEUTICALS
TECHNOLOGY OVERVIEW: PHARMACEUTICALS ISSUE 10.0 DECEMBER 1997 CLINICAL AND ECONOMIC CONSIDERATIONS IN THE USE OF FLUOROQUINOLONES based primarily on the Technical Report: An Analysis of the Use of Fluoroquinolones
More informationMembers are asked to: Support the uptake and development of the AWMSG National Audit: Focus on Antibiotic Prescribing.
Enclosure No: Agenda Item No: Author: Contact: 7/AWMSG/0215 11 Review of the AWMSG National Audit: Focus on Antibiotic Prescribing 2013 2015 All Wales Prescribing Advisory Group (AWPAG) Lead: TL Lewis
More informationDr Steve Holden Consultant Microbiologist Nottingham University Hospitals NHS Trust
Dr Steve Holden Consultant Microbiologist Nottingham University Hospitals NHS Trust Clinical Case 38 yrold man Renal replacement (CAPD) since 2011 Unexplained ESRF Visited Pakistan for 3 months end of
More informationNational Surveillance of Antimicrobial Resistance
National Surveillance of Antimicrobial Resistance Report to Ministry of Health by Sri Lanka College of Microbiologists SLCM ARSP & NLBSA Technical Committees December 2014 National Surveillance of Antimicrobial
More informationANTIMICROBIAL STEWARDSHIP IN PRIMARY CARE DR ROSEMARY IKRAM MBBS FRCPA CLINICAL MICROBIOLOGIST
ANTIMICROBIAL STEWARDSHIP IN PRIMARY CARE DR ROSEMARY IKRAM MBBS FRCPA CLINICAL MICROBIOLOGIST CONFLICTS OF INTEREST NONE PRESENTATION OUTLINE. SETTING THE SCENE WORLD AND NEW ZEALAND. BARRIERS TO OVERCOME.
More informationMedical Conditions Questionnaire
Medical Conditions Questionnaire (to be completed by the member) Member Full Name.Date of birth. Policy number or scheme name. Please complete the appropriate section(s) only after completing the Member
More informationAntimicrobial Stewardship in the Long Term Care and Outpatient Settings. Carlos Reyes Sacin, MD, AAHIVS
Antimicrobial Stewardship in the Long Term Care and Outpatient Settings Carlos Reyes Sacin, MD, AAHIVS Disclosure Speaker and consultant in HIV medicine for Gilead and Jansen Pharmaceuticals Objectives
More informationANTIBIOTIC USE GUIDELINES FOR URINARY TRACT AND RESPIRATORY DISEASE
ANTIBIOTIC USE GUIDELINES FOR URINARY TRACT AND RESPIRATORY DISEASE Jane Sykes, BVSc(Hons), PhD, DACVIM (SAIM) School of Veterinary Medicine Dept. of Medicine & Epidemiology University of California Davis,
More informationAre Dogs That Are Fed from a Raised Bowl at an Increased Risk of Gastric Dilation Volvulus Compared with Floor-Fed Dogs?
Are Dogs That Are Fed from a Raised Bowl at an Increased Risk of Gastric Dilation Volvulus Compared with Floor-Fed Dogs? A Knowledge Summary by Louise Buckley PhD RVN 1* 1 Harper Adams University, Edgmond,
More informationCore Elements of Antibiotic Stewardship for Nursing Homes
Core Elements of Antibiotic Stewardship for Nursing Homes Nimalie D. Stone, MD, MS Medical Epidemiologist for LTC Division of Healthcare Quality Promotion Centers for Disease Control and Prevention Antimicrobial
More informationUPDATE ON ANTIMICROBIAL STEWARDSHIP REGULATIONS AND IMPLEMENTATION OF AN AMS PROGRAM
UPDATE ON ANTIMICROBIAL STEWARDSHIP REGULATIONS AND IMPLEMENTATION OF AN AMS PROGRAM Diane Rhee, Pharm.D. Associate Professor of Pharmacy Practice Roseman University of Health Sciences Chair, Valley Health
More informationSurveillance for Antimicrobial Resistance and Preparation of an Enhanced Antibiogram at the Local Level. janet hindler
Surveillance for Antimicrobial Resistance and Preparation of an Enhanced Antibiogram at the Local Level janet hindler At the conclusion of this talk, you will be able to Describe CLSI M39-A3 recommendations
More information